Immune parameters in rapid cycling bipolar patients before and after lithium treatment

Journal of Psychiatric Research

Volumn 33, Issue 4, 1999, Pages 335-340

  Rapaport, Mark Hyman ^a,b   Guylai, Laszlo ^c   Whybrow, Peter ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; LITHIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNITY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL;

EID: 0032999574     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(99)00007-2     Document Type: Article

References (43)

1. Ahmann A.J., Burmann K.D. The role of T-lymphocytes in autoimmune thyroid disease. Endocrin Metabol Clin North Am. 16:1987;235-287.
2. Albrecht J., Hopf U. Humoral autoimmune phenomena under long-term treatment with lithium with special regard to thyroidal autoantibodies. Klin Wochenschr. 60:1982;1501-1504.
3. Diagnostic and statistical manual of mental disorders (DSM-III-R). 1987;American Psychiatric Association, Washington, DC.
4. Balazs C., Kiss E., Farid N. Effect of lithium on chemiluminescence of polymorphonuclear granulocytes and mononuclear cells in peripheral blood. Acta Medica Hungarica. 46:(1):1989;31-42.
5. Bartrop R.W., Lazarus L., Luckhurst E., Kiloh L.G., Penny R. Depressed lymphocyte function after bereavement. Lancet. 16:1977;834-836.
6. Bauer M.S., Crits-Christoph P., Ball W.A., Dewees E., McAllister T., Alahi P., Cacciola J., Whybrow P.C. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Archives of General Psychiatry. 48:(9):1991;807-812.
7. Bubak-Satora M., Skowron-Cendrzak A., Kubera M. The effect of lithium chloride treatment on cell-mediated immunity in mice. Felia Biologica. 39:1991;21-24.
8. Bubak-Satora M., Skowron-Cendrzak A., Kubera M., Holan V. Protective effect of lithium on the stress-induced depression of cell-mediated immunity in mice. Int J Immunopharmac. 16:(3):1994;233-237.
9. Calabrese J.R., Gulledge A.D., Hahn K., Skwerer R., Kotz M., Schumacher O.P., Gupta M.K., Krupp N., Gold P.W. Autoimmune thyroiditis in manic-depressive patients treated with lithium. Am J Psychiatr. 142:1985;1318-1321.
10. Del Prete G.F., Tiri A., Mariotti S., Parronchi P., Pinchera A., Romagnani S., Ricci M. Thyroiditis as a model of organ specific autoimmune disease. Clinical and Experimental Rheumatology. 3:1989;41-46.
11. Dunner D.L., Patrick V., Fieve R.R. Rapid cycling manic depressive patients. Compr Psychiatr. 18:1977;561-566.
12. Dunner D.L. A review of the diagnostic status of 'Bipolar II' for the DSM-IV work group on mood disorders. Depression. 1:1993;2-10.
13. Ebstein R.P., Lerer B., Bennett E.R., Dayek D.B., Newman M.E., Shapira B., Kindler S. Lithium modulation of second messenger signal amplification in man; inhibition of phosphatidylinositol-specific phospholipase C and adenylate cyclase activity. Psychiatr Res. 24:1988;45-52.
14. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., Rush A.J., Weissman M.M. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse and recurrence. Archives of General Psychiatry. 48:(9):1991;851-855.
15. Haggerty J.J., Evans D.L., Golden R.N., Pedersen C.A., Simon J.S., Nemeroff C.B. The presence of antithyroid antibodies in patients with affective and non-affective psychiatric disorders. Biol Psychiatr. 27:1990;51-60.
16. Haggerty J.J., Simon J., Evans D.L., Nemeroff C.B. Relationship of serum TSH concentration and antithyroid antibodies to diagnosis and DST response in psychiatric inpatients. Am J Psychiatr. 144:1987;1491-1493.
17. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 23:1960;56-62.
18. Hassman R.A., Lazarus J.H., Dieguez C., Weetman A.P., Hall R., McGregor A.M. The influence of lithium chloride on experimental autoimmune throid disease. Clin Exp Immonol. 61:1985;49-57.
19. Hornig M., Goodman D., Kamoun M., Amsterdam J. Journal of Affective Disorders. 49:1998;9-18.
20. Kleinerman E.S., Knowles R.D., Blick M.B., Zwelling L.A. Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin. Journal of Leukocyte Biology. 46:1989;484-492.
21. Kronfol Z., Hamdan-Allen G., Black D.W. Fever and leukocytosis: physical manifestations of bipolar affective disorder? Prog Neuro-Psychopharmacol Biol Psychiatr. 12:1988;887-891.
22. Kronfol Z., House J.D. Immune function mania. Biol Psychiatr. 24:1988;341-343.
23. Kronfol Z., Turner R., House J.D., Winokur W.E. Elevated blood nueutrophil concentrations in mania. J Clin Psychiatr. 47:1984;63-65.
24. Kubera M., Bubak-Satora M., Holan V., Krol W., Basta-Kaim A., Roman A., Skowron-Cendrzak A., Shani J. Modulation of cell-mediated immunity by lithium chloride. 1994;Verlag der Zeitschrift fuer Naturforschung.
25. Kucharz E.J., Sierakowski S.J., Goodwin J.S. Lithium in vitro enhances interleukin-2 production by T-cells from patients with systemic lupus erythematosus. Immunopharmacology and Immunotoxicology. 15:(5):1993;515-523.
26. Licastro F., Mariella Chircolo M., Tabacchi P., Barboni F., Zannotti, Franceschi C. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and down's syndrome subjects. Cellular Immunology. 75:1983;111-121.
27. Lieb J. Lithium and immune function. Medical Hypotheses. 23:1987;73-93.
28. Loranger A.W. Personality disorders examination. 1988;D.V, New York.
29. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 29:1995;141-152.
30. Maes M., Delange J., Ranjan R., Meltzer H.Y., Desnyder R., Cooremans W., Scharpe S. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiat Res. 66:1997;1-11.
31. Manji H.K. G proteins: implications for psychiatry. Am J Psychiatr. 149:1992;746-760.
32. Manji H.K., Bitran J.A., Masana M.I., Chen G., Hsiao J.K., Risby E.D., Rudorfer M.V., Potter W.Z. Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies. Psychopharmacol Bull. 27:1991;199-208.
33. Manji H.K., Hsiao J.K., Risby F.D., Rudorfer M.V., Potter W.Z. The mechanisms of action of lithium: effects on serotoninergic and nonadrenergic systems on normal controls. Arch Gen Psychiatr. 48:1991;505-512.
34. Mori M., Tajima K., Oda Y., Matsui I., Mashita K., Tarui S. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system. Endocrinology. 124:(3):1989;1365-1369.
35. Mork A., Geisler A. The effects of lithium in vitro and in vivo on adenylate cyclase in brain are exerted by distinct mechanism. Neuropharmacology. 28:1989;307-311.
36. Muller N., Ackenheil M., Hofschuster E. Altered T-cell number and reduced suppressor cell activity in patients with affective psychosis. Interaction Among CNS, Neuroendocrine and Immune Systems. 31:1989;385-394.
37. Muller N., Hospchuster E., Ackenheil M., Mempel W., Eckstein R. Investigations of the cellular immunity during depression and the free interval evidence for an immune activation in affective psychosis. Prog Neuro-Psychopharmacol Biol Psychiatr. 17:1993;713-730.
38. Rapaport M.H. Immune parameters in euthymic bipolar patients and normal volunteers. J Affect Disord. 32:1994;149-156.
39. Rapaport M., Schmidt M., Risinger R., Manji H. The effects of prolonged lithium exposure on the immune system of normal control subjects: Serial serum soluble interleukin-2 receptor and antithyroid antibody measurements. Biol Psychiatr. 35:1994;761-766.
40. Song C., Leonard B.E. The effects of chronic lithium chloride administration on some behavioural and immunological changes in the bilaterally olfactory bulbectomized rat. Journal of Psychopharmacology. 8:(1):1994;40-47.
41. Sluzewska A., Sobieska M., Rybakowski J.K. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology. 35:1997;123-127.
42. Yang Z.W., Chengappa R., Shurin G., Rabin B.S., Ganguli R. Low IL-2 production in schizophrenic patients is correlated with the clinical state and the presence of autoantibodies. Biol Psychiatry. 31:(5A):1992;207A.
43. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry. 133:1978;429-435.